About Miacom Diagnostics
Miacom Diagnostics is a Healthcare company based in Dusseldorf (Germany) founded in 2006, and was acquired by MetaSystems in December 2017. Rapid molecular diagnostics for infectious diseases. The company was acqui-hired. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Bacterial.
Company details
Miacom Diagnostics develops rapid molecular diagnostics for infectious diseases. Its platform FISH technology uses proprietary Miacom beacon probes that get excited in the presence of target microbes. This technology can also be used in multiplex tests. First applications are for the detection of sepsis and pneumonia, but custom probes can also be made for research purposes. In July 2014, Shanghai Fosun Pharmaceutical Group acquired a 37 stake in the company.
- Headquarters Dusseldorf, Germany
- Stage Acquired
- SectorsHealthcare
- Website miacom-diagnostics.com
- Social LinkedIn
- Acquired by MetaSystems (Dec 2017)
- InvestorsFosun
& 2 more
- Acquired byMetaSystems
(Dec 2017)
Funding Insights of Miacom Diagnostics
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Miacom Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2014 | Series A | – | Fosun | – | |
| Apr 2009 | Series A | – | Inveni Capital | – |
3 investors in total: 3 institutional.
Investors in Miacom Diagnostics
Miacom Diagnostics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Fosun, Inveni Capital and MetaSystems.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| invenicapital.com | ||||
Diversified investment, asset management, and insurance services are offered globally. | 1992 | fosun.com | Shanghai, China | |
Automated imaging solutions are provided by MetaSystems for laboratories. | 1986 | metasystems-international.com |
Investor details for Miacom Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Miacom Diagnostics
4 dated milestones of Miacom Diagnostics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Miacom Diagnostics is founded.
- Funding First funding round.
- Funding Latest funding round, Series A,.
- Exit Acquired by MetaSystems.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Miacom Diagnostics
Miacom Diagnostics was founded in 2006 and raised its 1st funding round 3 years after it was founded.
Miacom Diagnostics is headquartered in Dusseldorf, Germany. It is registered at Dusseldorf, North Rhine-westphalia, Germany.
Miacom Diagnostics develops rapid molecular diagnostics for infectious diseases. Its platform FISH technology uses proprietary Miacom beacon probes that get excited in the presence of target microbes. This technology can also be used in multiplex tests. First applications are for the detection of sepsis and pneumonia, but custom probes can also be made for research purposes. In July 2014, Shanghai Fosun Pharmaceutical Group acquired a 37 stake in the company.
Miacom Diagnostics has 3 investors. Key investors include Fosun, Inveni Capital, and MetaSystems.
Yes. Miacom Diagnostics was acquired by MetaSystems in December 2017.